These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2883072)

  • 1. The effects of chronic treatment with fencamfamine on body weight, food intake and stereotyped behaviour in rats.
    DeLucia R; Aizenstein ML; Scavone C; Planeta Cda S
    Gen Pharmacol; 1987; 18(3):299-301. PubMed ID: 2883072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of phenoxybenzamine on the stereotyped behaviour induced by fencamfamine in rats: evidence for a qualitative alteration.
    Bernardi MM; Aizenstein ML; DeLucia R; Scavone C
    Gen Pharmacol; 1985; 16(4):403-5. PubMed ID: 4043717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effects of long-term administration of fencamfamine: neurochemical implications.
    Planeta CS; Scavone C; De Lucia R; Aizenstein ML
    Gen Pharmacol; 1987; 18(4):347-9. PubMed ID: 3609692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of central stimulation action of fencamfamine.
    DeLucia R; Bernardi MM; Scavone C; Aizenstein ML
    Gen Pharmacol; 1984; 15(5):407-10. PubMed ID: 6150875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization.
    Aizenstein ML; Segal DS; Kuczenski R
    Neuropsychopharmacology; 1990 Aug; 3(4):283-90. PubMed ID: 1976010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of food intake by fencamfamine in rats.
    DeLucia R; Planeta Cda S; Scavone C; Aizenstein ML
    Gen Pharmacol; 1987; 18(1):21-3. PubMed ID: 2881832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism which mediates the effects of long-term administration of fencamfamine in rats.
    Planeta CS; DeLucia R; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1989; 22(7):881-3. PubMed ID: 2576524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C; De Lucia R; Bernardi MM; Aizenstein ML
    Eur J Pharmacol; 1985 May; 112(1):11-6. PubMed ID: 4040467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative biochemical and behavioural effects of fencamfamine and dl-amphetamine in rats.
    Aizenstein ML; Scavone C; Bernardi MM; Delucia R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):187-94. PubMed ID: 6684314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties and schedule effects of fencamfamine in rats.
    Risner ME; Jackson-Smith PA; Cone EJ
    Pharmacol Biochem Behav; 1985 Sep; 23(3):449-56. PubMed ID: 2864703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine uptake inhibiting versus dopamine releasing properties of fencamfamine: an in vitro study.
    Seyfried CA
    Biochem Pharmacol; 1983 Aug; 32(15):2329-31. PubMed ID: 6136281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apomorphine on rat motor activity induced by fencamfamine and other indirect psychostimulant drugs.
    Aizenstein ML; da-Silva-Planeta C; DeLucia R; da-Silva CS
    Braz J Med Biol Res; 1995 Sep; 28(9):995-8. PubMed ID: 8580889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of fencamfamine on rats: a chronobiologic approach.
    Planeta Cda S; Aizenstein ML; Scavone C; DeLucia R
    Chronobiol Int; 1989; 6(4):313-20. PubMed ID: 2483362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fencamfamine.
    DeLucia R; Planeta CS
    Gen Pharmacol; 1990; 21(2):161-3. PubMed ID: 1970543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fencamfamine on avoidance performances of rats.
    DeLucia R; Aizenstein ML; Planeta CS
    Braz J Med Biol Res; 1991; 24(3):307-9. PubMed ID: 1823244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fencamfamine withdrawal in rats.
    Planeta CS; DeLucia R; Aizenstein ML
    Gen Pharmacol; 1994 Sep; 25(5):931-4. PubMed ID: 7835639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of changes in apomorphine-induced stereotyped behaviour in rats receiving continuous administration of trifluorperazine for 15 months.
    Rupniak NM; Boyce S; Jenner P; Marsden CD
    Neuropharmacology; 1984 Aug; 23(8):893-8. PubMed ID: 6148709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated administration intensifies the reinforcing effect of fencamfamine in rats.
    DeLucia R; Planeta CS; Aizenstein ML; Scavone C
    Gen Pharmacol; 1997 Aug; 29(2):265-7. PubMed ID: 9251911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M; Leonard BE
    J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swimming capacity of mice after prolonged treatment with psychostimulants. III. Effect of fencamfamine on swimming endurance and availability of metabolic substrates.
    Estler CJ; Gabrys MK
    Psychopharmacology (Berl); 1979 Jun; 63(3):281-4. PubMed ID: 39309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.